Analyst Price Target is $79.89
▲ +7.93% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Encompass Health in the last 3 months. The average price target is $79.89, with a high forecast of $86.00 and a low forecast of $71.00. The average price target represents a 7.93% upside from the last price of $74.02.
Current Consensus is
The current consensus among 8 polled investment analysts is to buy stock in Encompass Health. This Buy consensus rating has held steady for over two years.
Encompass Health Corporation provides post-acute healthcare services in the United States. It provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides services under the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.